All Pharma articles – Page 6
-
NewsHunt tells Hancock to ‘use his magic’ to secure high cost drug approval
Former health secretary Jeremy Hunt has urged his successor to find a way to ensure patients can access a high cost drug which is subject to a legal challenge against the National Institute for Health and Care Excellence.
-
NewsUp to 100,000 on antipsychotics with no review
A national strategy is needed to tackle health risks linked to antipsychotic drugs because current policy is letting tens of thousands of people fall through the gaps, commissioners in London are warning.
-
HSJ InteractiveGetting the most out of medicines
A panel of experts explored how understanding what patients want out of medicines and redefining the concept of ‘value’ are at the heart of the growing challenge of medicines adherence
-
CommentThe NHS's role in the climate emergency
Reducing the NHS’s carbon footprint by choosing greener alternatives can make a significant contribution to tackling climate change, writes Elaine Winkley
-
CommentWhy primary care transformation is key to reducing CVD
The rising incidence of cardiovascular disease means its early detection and improved prevention should be the primary care sector’s top priority argues Dr Matt Kearney
-
CommentInternational comparisons highlight the challenges for the NHS
If the UK is to maintain its efficiency gains while strengthening the resilience of the NHS it must integrate and innovate across health and care, writes Dr Layla McCay
-
CommentWhy NHS drugs should be ‘on the table’ in trade talks
If patients are to benefit from the most advanced treatments, pharmaceuticals must be on the table in UK trade talks, says Tony Hockley.
-
CommentSwindells: politicians are fighting a 40 year-old battle over the NHS
The next wave of healthcare transformation will be a multi-industry partnership, writes Matthew Swindells
-
HSJ AwardsHSJ Awards 2019: Patient safety award
WINNER: Wessex Academic Health Science Network – National Polypharmacy Prescribing Comparators
-
HSJ AwardsHSJ Awards 2019: HSJ partnership of the year
WINNER: Gilead Sciences, CGL and the NHS – Gilead partnering with Drug Treatment Services (and the NHS) to support eliminating Hepatitis C
-
HSJ AwardsHSJ Awards 2019: Community or primary care service redesign – North, Midlands and East
WINNER: Hull Clinical Commissioning Group – The Jean Bishop Integrated Care Centre
-
NewsNHS use of e-prescribing can be a ‘risk to patient safety’
Poorly-implemented electronic prescribing systems in NHS hospitals are putting patients’ lives at risk, the NHS’s safety watchdog has warned.
-
Expert BriefingAbout that bus…?: What the Boris deal means for the NHS: a bitesize guide
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman. Contact me in confidence.
-
NewsNHS England finally strikes deal for high value drug
A deal has been struck to make a life-extending cystic fibrosis drug available on the NHS for the first time.
-
NewsNew Brexit plan worse for NHS than May’s deal, experts warn
The NHS will be exposed to more risk by the government’s latest Brexit deal than by Theresa May’s original agreement, health service experts and lobby groups have told HSJ.
-
Expert BriefingFollowing the Money: At last, the ‘truth’ about NHS privatisation
HSJ’s expert briefing on NHS finances, savings and efforts to get the health service back in the black. This week by HSJ editor Alastair McLellan.
-
Expert Briefing‘About that bus…?’: In short supply this winter
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman. Contact me in confidence.
-
NewsMinisters confirm ban on some drug exports ahead of Brexit deadline
Ministers have confirmed plans for a ban on the export of certain medicines, starting with a group of 24 drugs including 19 hormone replacement therapy treatments, ahead of the no-deal Brexit deadline at the end of this month.
-
Expert Briefing‘About that bus…?’: Ministers’ tactics to see off threat of a Brexit drugs sell-off revealed
Welcome to the ‘About that bus…?’ weekly newsletter – giving you the inside track on how the fallout from Brexit is affecting the NHS at national and local level, edited by James Illman. Contact me in confidence.
-
CommentThe dangers of Labour's attempt to cut drug costs
The Labour party’s proposals aimed at drug costs are radical but risky, writes Tony Hockley